feed,title,long_url,short_url
Benzinga,AnaptysBio's Imsidolimab Fails To Separate From Placebo In Skin Blistering Disorder Study,https://benzinga.com/general/biotech/21/03/20053279/anaptysbios-imsidolimab-fails-to-separate-from-placebo-in-skin-blistering-disorder-study,https://j.mp/3qrfRb9
